Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. (US Food Recalls) More
Torrent Pharmaceuticals Limited is voluntarily recalling 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlorothiazide tablets, ...
Posted on 1 March 2019 | 3:00 am | Google News
Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer ...
Posted on 22 February 2019 | 3:00 am | Google News
The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have ...
Posted on 8 February 2019 | 3:00 am | Google News
PITTSBURGH - Another day, another problem for blood pressure medications, and it's starting to frustrate Cindy Bryan who takes her pills daily. "Even the ...
Posted on 1 February 2019 | 3:00 am | Google News
Six Additional Lots of Losartan Tablets Recalled Pharmacy Times
Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and ...
Posted on 23 January 2019 | 3:00 am | Google News
Losartan Recall Expanded for Cancer-Causing Impurity Daily Hornet
A recent recall for the generic blood pressure medication Losartan has been expanded because it may contain a cancer-causing impurity.
Posted on 8 January 2019 | 3:00 am | Google News
Copyright © 2019 LastMinuteStuff.com